Recomandările naționale ale Societății Croate de Biochimie și Medicină de Laborator pentru recoltarea, prelucrarea probelor de sânge, performanța testării și raportarea rezultatelor pentru testele screening de hemostază: timp de protrombină, timp de tromboplastină parțială activată, timp de trombină, fibrinogen și D-dimeri

1 Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New Fundamentals in Hemostasis. Physiol Rev. 2013;93:327-58. DOI: 10.1152/physrev.00016.2011 Search in Google Scholar

2 Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb). 2010;20:184-99. DOI: 10.11613/BM.2010.023 Search in Google Scholar

3 Harris NS, Bazydlo LAL, Winter WE. A Primer on Haemostasis for Clinical Chemists.Clinical Laboratory News 2012. Available at: https://www.aacc.org/publications/cln/articles2012/January/coagulation-tests. Accessed March 17th 2016. Search in Google Scholar

4 Chandler WL, ed. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 63-71. DOI: 10.1002/9781444303575.ch7 Search in Google Scholar

5 Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in haemostasis. Lab Med. 2012;43:1-10. DOI: 10.1309/LM749BQETKYPYPVM Search in Google Scholar

6 Bronić A, Coen Herak D, Margetić S, Milić M. Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb). 2017;27:199-216. DOI: 10.11613/BM.2017.022 Search in Google Scholar

7 Lippi G, Favaloro EJ, eds. Causes of errors in medical laboratories. In Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 22-31. DOI: 10.1002/9781118543467.ch3 Search in Google Scholar

8 Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49. DOI: 10.1186/s12959-016-0123-z Search in Google Scholar

9 Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017;1646:29-42. DOI: 10.1007/978-1-4939-7196-1_2 Search in Google Scholar

10 Nikolac N, Šupak-Smolčić V, Šimundić AM, Ćelap I. Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling. Biochem Med (Zagreb). 2013;23:242-54. DOI: 10.11613/BM.2013.031 Search in Google Scholar

11 Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline-Fifth Edition. CLSI document H21-A5. Wayne: CLSI; 2008. Search in Google Scholar

12 Adcock DM, Kressin DC, Marlar RA. Minimum Specimen Volume Requirements for Routine Coagulation Testing Dependence on Citrate Concentration. Am J Clin Pathol. 1998;109;595-9. DOI: 10.1093/ajcp/109.5.595 Search in Google Scholar

13 Bennett ST, ed. Collection of Coagulation Specimens. In: Bennett ST, Lehman CM, Rodgers GM, eds. Laboratory Hemostasis - A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2015. p.19-32. DOI: 10.1007/978-3-319-08924-9_2 Search in Google Scholar

14 Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Gu- idi GC, Favaloro EJ. Quality Standards for Sample Collection in Coagulation Testing. Semin Thromb Hemost. 2012;38: 565-75. DOI: 10.1055/s-0032-1315961 Search in Google Scholar

15 Laxson CJ, Titler MG. Drawing coagulation studies from arterial lines; an integrative literature review. Am J Critical Care. 1994;3:16-22. DOI: 10.4037/ajcc1994.3.1.16 Search in Google Scholar

16 Adcock Funk D, ed. Sample integrity and preanalytical variables. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 45-56. DOI: 10.1002/9781118543467.ch5 Search in Google Scholar

17 Suchsland J, Friedrich N, Grotevendt A, Kallner A, Lüdemann J, Nauck M, Petersmann A. Optimizing centrifugation of coagulation samples in laboratory automation. Clin Chem Lab Med. 2014;52:1187-91. DOI: 10.1515/cclm-2014-0038 Search in Google Scholar

18 Marlar RA, Potts MR, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol. 2006;126:400-5. DOI: 10.1309/RRQKT2JEYV33D19D Search in Google Scholar

19 Lippi G, Plebani M, Favarolo EJ. Interference in coagulation testing: Focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2013;39:258-66. DOI: 10.1055/s-0032-1328972 Search in Google Scholar

20 Adcock Funk DM, Lippi G, Favaloro EJ. Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing. Semin Thromb Hemost. 2012;38:576-85. DOI: 10.1055/s-0032-1319768 Search in Google Scholar

21 van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-Site blood collection: Influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8. DOI: 10.1373/clinchem.2004.043174 Search in Google Scholar

22 Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand Disorder due to cold activation of blood samples for testing. Am J Clin Path. 2004;122;686-92. DOI: 10.1309/E4947DG48TVY19C2 Search in Google Scholar

23 Lima-Oliveira G, Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Clin Biochem. 2016;49:1399-401. DOI: 10.1016/j.clinbiochem.2016.10.009 Search in Google Scholar

24 Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effects of storage and thawing conditions on coagulation testing. Int J Lab Hematol. 2015;37:551-9. DOI: 10.1111/ijlh.12342 Search in Google Scholar

25 Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M; British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 2013;35:1-13. DOI: 10.1111/ijlh.12004 Search in Google Scholar

26 Gardiner C, Kitchen S, Dauer RJ, Kottke-Marchant K, Adcock DM. Recommendations for evaluation of coagulation analyzers. Lab Hematol. 2006;12:32-8. DOI: 10.1532/LH96.05031 Search in Google Scholar

27 Kitchen S, Preston EF, Olson JD, eds. Internal Quality Control in the hemostasis Laboratory. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 57-64. DOI: 10.1002/9781118543467.ch6 Search in Google Scholar

28 Preston EF, Kitchen S, Srivastava A, eds. External Quality Assessment in Hemostasis: Its Importance and Significance. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 65-76. DOI: 10.1002/9781118543467.ch7 Search in Google Scholar

29 Clinical and Laboratory Standard Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline-Second Edition H47-A2, Wayne: CLSI; 2008. Search in Google Scholar

30 Tripodi A, ed. Monitoring Oral Anticoagulant Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 253-63. DOI: 10.1002/9781118543467.ch22 Search in Google Scholar

31 Bonar R, Favaloro EJ. Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio. Thromb Res. 2017;150:22-9. DOI: 10.1016/j. thromres.2016.12.007 Search in Google Scholar

32 Clinical and Laboratory Standards Institute (CLSI). Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline. CLSI guideline H54-A. Wayne: CLSI; 2005. Search in Google Scholar

33 Croatian Chamber of Medical Biochemists. [Harmonizacija laboratorijskih nalaza u području opće medicinske biokemije.] Available at: http://www.hkmb.hr/obavijesti/obavije-sti-index.html. Accessed March 21th 2016. (in Croatian). Search in Google Scholar

34 Lippi G, Favaloro EJ. Activated partial thromboplastin time: New tricks for an old dogma. Semin Thromb Hemost. 2008;34:604-11. DOI: 10.1055/s-0028-1104539 Search in Google Scholar

35 Johnston M, ed. Monitoring Heparin Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 224-52. DOI: 10.1002/9781118543467.ch21 Search in Google Scholar

36 Brill-EdvardsP, Gunsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-9. DOI: 10.7326/0003-4819-119-2-199307150-00002 Search in Google Scholar

37 Marlar RA, Gausman J. The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time - based heparin therapeutic range. Arch Pathol Lab Med. 2013;137:77-82. DOI: 10.5858/arpa.2011-0516-OA Search in Google Scholar

38 Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy; the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998;122:799-807 Search in Google Scholar

39 Rodgers GM, Lehman CM, eds. Hemostasis Screening Assays. In: Bennett ST, Lehman CM, Rodgers GM. Laboratory Hemostasis: A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2007.p.85-101. DOI: 10.1007/0-387-36840-X_5 Search in Google Scholar

40 Teruya J. Thrombin Time. Available at: https://emedicine.medscape.com/article/2086278-overview . Accessed March 21th 2016. Search in Google Scholar

41 Ariëns RA. Fibrin(ogen) and thrombotic disease. J Thromb Haemost. 2013;11:294-305. DOI: 10.1111/jth.12229 Search in Google Scholar

42 Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. On Behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003;121:396-404. DOI: 10.1046/j.1365-2141.2003.04256.x Search in Google Scholar

43 van den Besselaar AMHP, van Rijn CJJ, Cobbaert CM, Reijnierse GLA, Hollestelle MJ, Niessen R. et al. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples. Clin Chem Lab Med. 2017; 55:1761-9. DOI: 10.1515/cclm-2016-1088 Search in Google Scholar

44 Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126:e428-33. DOI: 10.1016/j.thromres.2010.09.004 Search in Google Scholar

45 Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the “derived” fibrinogen measurement. Blood Coagul Fibrinol. 1994;5:955-7. DOI: 10.1097/00001721-199412000-00012 Search in Google Scholar

46 Olson JD, Cunningham MT, Higgins RA, Eby CS, Brandt JT. D-dimer: simple test, tough problems. Arch Pathol Lab Med. 2013;137:1030-8. DOI: 10.5858/arpa.2012-0296-CP Search in Google Scholar

47 Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287-93. DOI: 10.1055/s-0035-1549092 Search in Google Scholar

48 Clinical and Laboratory Standards Institute (CLSI). Quantitative D-Dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Wayne: CLSI; 2011. Search in Google Scholar

49 Oude Elferink RFM, Loot AE, Van de Klashorst CGJ, Hulsebos-Huygen M, Piersma-Wichers M, Oudega R. Clinical evaluation of eight different D-dimer test for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230-8. DOI: 10.3109/00365513.2014.993697 Search in Google Scholar

50 Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97:1507-13. DOI: 10.3324/haematol.2011.060657 Search in Google Scholar

51 Favaloro EJ, Lippi G. Laboratory reporting of haemostasis assays: The final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med. 2010;48:309-21. DOI: 10.1515/CCLM.2010.061 Search in Google Scholar

52 Marlar RA, ed. Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 13-21. DOI: 10.1002/9781118543467.ch2 Search in Google Scholar

53 Castellone DD. Establishing reference intervals in the coagulation laboratory. Int J Lab Hematol. 2017;39:121-27. DOI: 10.1111/ijlh.12661 Search in Google Scholar

54 Ignjatovic V, Kenet G, Monagle P, on behalf of the Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting paediatric samples. J Thromb Haemost. 2012;10:298-300. DOI: 10.1111/j.1538-7836.2011.04584.x Search in Google Scholar

55 Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54:215-22. DOI: 10.1515/cclm-2015-0657 Search in Google Scholar

56 Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J, Plebani M. IFCC WG harmonization of quality assessment of interpretative comments. Clin Chem Lab Med. 2016;54:1901-11. DOI: 10.1515/cclm-2016-0709 Search in Google Scholar

57 Lippi G, Adcock D, Simundic AM, Tripodi A, Favaloro EJ. Critical laboratory values in hemostasis: toward consensus. Ann Med. 2017;49:455-461. DOI: 10.1080/07853890.2016.1278303 Search in Google Scholar

58 Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133:160S-98S. DOI: 10.1378/chest.08-0670 Search in Google Scholar

59 Pai M, Moffat KA, Plumhoff E, Hayward CM. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol. 2011;136:836-41. DOI: 10.1309/AJCP8O8GIPPPNUSH Search in Google Scholar

60 Don-Wauchope AC, Chetty VT. Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values? Clin Biochem. 2009;42:766-70. DOI: 10.1016/j. clinbiochem.2009.02.016 Search in Google Scholar

61 Huber AR, Méndez A, Brunner-Agten S. Automation in haemostasis. Hamostaseologie. 2013;33:295-8. DOI: 10.5482/HAMO-12-05-0002 Search in Google Scholar